ALEXANDRIA, Va., July 28 -- United States Patent no. 12,693,290, issued on July 28, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).
"Interference-suppressed pharmacokinetic immunoassay" was invented by Gregor Jordan (Grobenzell, Germany), Achim Lutz (Iffeldorf, Germany) and Maria Viert (Penzberg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Herein is reported a method for the determination of a bispecific antibody in a serum-containing sample comprising the steps of first incubating a solid phase to which a capture antibody specifically binding to the bispecific antibody has been immobilized with the sample to form an immobilized capture antibody-bispecific antibody-complex, thereafter...